1994
DOI: 10.1097/00006982-199414040-00005
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Perfluoro-Octane in the Management of Giant Retinal Tears Without Proliferative Vitreoretinopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Surgeons advocating the use of scleral buckles argue that a high circumferential indentation could counteract any future contraction of the vitreous base and, hence, decrease recurrence rates. 18 Others are in favor of radical vitreous base removal without buckling in cases with no significant PVR to avoid potential buckle complications such as fishmouthing, tear slippage and choroidal hemorrhage. [19][20][21] Posterior tear slippage is even more of a risk during fluid-air exchange.…”
Section: Discussionmentioning
confidence: 99%
“…Surgeons advocating the use of scleral buckles argue that a high circumferential indentation could counteract any future contraction of the vitreous base and, hence, decrease recurrence rates. 18 Others are in favor of radical vitreous base removal without buckling in cases with no significant PVR to avoid potential buckle complications such as fishmouthing, tear slippage and choroidal hemorrhage. [19][20][21] Posterior tear slippage is even more of a risk during fluid-air exchange.…”
Section: Discussionmentioning
confidence: 99%
“…Perfluorocarbon liquids (PFCLs), a high specific gravity and hydrophobic liquid began to be used for flap eversion and retinal positioning in the early 1990s. 27,[65][66][67][68] Perfluorocarbons are injected into the vitreous cavity to unfold the GRT flap and flatten the retina against the RPE. This allows reliable flap eversion and subsequent retinopexy with minimal iatrogenic injury.…”
Section: Treatmentmentioning
confidence: 99%